logo
Birlasoft shares slide over 6% in 2 days post Q4 earnings miss; Nuvama slashes target price on bleak outlook

Birlasoft shares slide over 6% in 2 days post Q4 earnings miss; Nuvama slashes target price on bleak outlook

Time of India30-05-2025

Shares of
Birlasoft Ltd
have dropped 6.4% over two sessions since the company reported its fourth-quarter earnings, with the stock falling as much as 5.8% on Friday to Rs 396 on the BSE. The slide comes after the IT services firm posted a sequential decline in revenue and a tepid outlook, prompting
Nuvama
Institutional Equities to slash its target price and reiterate a negative stance.
Nuvama lowered its 12-month target price on
Birlasoft
to Rs 350 from Rs 370, maintaining a 'reduce' rating. The revised target implies a potential downside of about 11.6% from Friday's low.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
New Container Houses Indonesia (Prices May Surprise You)
Container House | Search ads
Search Now
Undo
"Birlasoft reported weak Q4FY25 results," Nuvama said in a post-results note, adding that the company missed the brokerage's estimates. 'Birlasoft continues to disappoint on revenue growth,' it added, citing the weakest annual growth across its coverage universe apart from Wipro.
For the March quarter, Birlasoft's consolidated revenue fell 3.36% QoQ to Rs 1,316.89 crore, and 3.35% YoY. In dollar terms, revenue stood at USD 152.2 million, down 5.4% QoQ and 7.2% YoY. Constant currency revenue fell 5.3% QoQ.
Despite the revenue miss, operating margins improved, with EBITDA rising 6.2% QoQ to Rs 173.6 crore. EBITDA margin expanded to 13.2% from 12% in the previous quarter, although it was down from 16.3% a year earlier. EBIT margin also rose by 110 basis points QoQ to 11.5%, beating Nuvama's estimate of 10.7%.
Live Events
Management attributed the margin gains to operating efficiencies and one-off benefits, including lower variable pay and currency gains, which contributed around 200 basis points to the expansion.
Project ramp-downs, segment weakness
The top-line pressure was largely due to project closures and ramp-downs in key verticals. 'Revenue declined 5.3% CC QoQ/6.9% CC YoY due to higher-than-usual furloughs extending into January, some project closures and ramp-downs in a couple of large accounts, mainly in the Manufacturing and Lifesciences segments,' Nuvama said.
The company highlighted leadership changes in underperforming verticals, including Manufacturing and the MedTech segment within Lifesciences. The ERP segment also continued to decline, falling 7% QoQ.
Among verticals, Energy & Utilities (E&U) was the only segment to post growth, rising 1.9% QoQ, while Lifesciences, Manufacturing, and BFSI declined 7.2%, 6.8% and 5.7% QoQ, respectively.
Growth revival expected from Q2
The management indicated a muted Q1 FY26, with growth expected to pick up from Q2 onwards, while margins are expected to remain in a narrow band through FY26.
"Management highlighted a muted Q1 in terms of growth and deal-wins with growth starting from Q2. Management's endeavour is a better FY26 than FY25 while EBITDA margin are likely to remain in a similar range," Nuvama said noting the company's post-earnings call.
Full-year FY25 performance remained soft, with constant currency revenue flat, margins contracting 280 basis points, and total TCV declining 13% YoY. Net new deal TCV was down 20% YoY.
'Birlasoft has had a disappointing FY25 on all fronts,' Nuvama said. 'A weak exit run rate in Q4 along with tepid TCV in FY25 raises serious concern about FY26 growth prospects. We continue to be negative as we see little respite in the near term.'
TCV stable, but net wins still subdued
Total contract value (TCV) for Q4 came in at $236 million, up 4% QoQ but down 2% YoY, including $112 million in new deals and $124 million in renewals. Net new deal wins grew 5% YoY, indicating some momentum despite the overall soft environment.
Management said it is using 'its specialised domain expertise within each of the verticals and sub-verticals together with technology capabilities to create an offering.' The company is also focusing on organic growth, with no mention of M&A-led expansion.
The post-earnings decline suggests investor concerns about the company's weak growth visibility and execution risks. Birlasoft's efforts to revive momentum through leadership changes and operational efficiencies have yet to reassure the market, as the stock now trades close to the revised target price set by analysts.
'Growth remains elusive,' Nuvama concluded, underscoring persistent challenges for the mid-tier IT firm as it navigates a tough demand environment and attempts to rebuild its growth engine in FY26.
Also read |
Market surge leads to Rs 50,000 crore worth stake sales by promoters and shareholders
(
Disclaimer
: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Did Elon Musk use ketamine, ecstasy drugs? What Donald Trump said
Did Elon Musk use ketamine, ecstasy drugs? What Donald Trump said

Time of India

time26 minutes ago

  • Time of India

Did Elon Musk use ketamine, ecstasy drugs? What Donald Trump said

Elon Musk with Donald Trump (File photo) US President Donald Trump on Monday responded cautiously to recent reports alleging Elon Musk used recreational drugs while advising his administration, calling the claims troubling but unverified. "I really don't know. I don't think so," Trump told reporters on June 9 when asked whether Musk had brought drugs into the White House. "I hope not." The remark marks Trump's first major comment on the issue since The New York Times reported in late May that Musk had allegedly used ketamine, ecstasy, and psychedelic mushrooms while campaigning with Trump in 2024. The report cited unnamed sources. Musk swiftly responded to the allegations in a post on X: "You can tell immediately that someone is a massive liar if they're claiming I'm on drugs, as I am one of the most photographed people on Earth and am in meetings 7 days a week!" He added that he underwent random drug testing for nearly three years following a widely-publicized 2018 podcast appearance with Joe Rogan . "Not the slightest trace of drugs or alcohol was found." USA Today reported it remains unclear whether Musk used any substances while serving in an official capacity. When asked about it on his final day as a special government employee, Musk avoided the question, saying, 'Let's move on.' The drug allegations come amid a broader fallout between Trump and Musk. Their once-close relationship soured after Musk denounced Trump's tax and spending package as a 'disgusting abomination.' by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Sanitize & Smooth Clothes Fast with Philips Steamer Philips Garment Steamers Shop Now Undo Trump retaliated by suggesting he might scale back federal contracts held by Musk's companies, while Musk hinted that Trump appeared in classified files related to convicted sex offender Jeffrey Epstein. Despite the tensions, signs of de-escalation have emerged. Trump took a softer stance when asked about Musk's satellite internet company, Starlink. 'It's a good service,' he said, indicating no plans to discontinue its use at the White House. He also struck a conciliatory note personally, saying: 'We had a good relationship, and I just wish him well.' The highly public spat has complicated Republican efforts to pass Trump's 'big, beautiful bill' in Congress, where the GOP holds narrow majorities. However, with Musk deleting earlier posts—some of which had supported impeachment—insiders suggest the billionaire may be ready to mend ties with the president.

Adani Power share price jumps 8% with strong surge in volume; looks set to extend gains to 5th session in a row
Adani Power share price jumps 8% with strong surge in volume; looks set to extend gains to 5th session in a row

Mint

time28 minutes ago

  • Mint

Adani Power share price jumps 8% with strong surge in volume; looks set to extend gains to 5th session in a row

Adani Power share price jumped over 8% in intraday trade on the BSE on Tuesday, June 10, looking set to extend gains to the fifth consecutive session. Adani Power share price opened at ₹ 565.30 against its previous close of ₹ 563.30 and jumped 8.3 per cent to an intraday high of ₹ 610. Around 2:45 PM, the Adani Group stock traded 6.33 per cent higher at ₹ 598.95, with over 2.60 crore shares traded. (This is a developing story. Please check back for fresh updates.)

8th Pay Commission salary hike may miss January 2026 deadline: Will it impact fitment factor calculation?
8th Pay Commission salary hike may miss January 2026 deadline: Will it impact fitment factor calculation?

Time of India

time31 minutes ago

  • Time of India

8th Pay Commission salary hike may miss January 2026 deadline: Will it impact fitment factor calculation?

Why the 8th Pay Commission might be delayed beyond January 2026? Live Events Fitment factor Dearness Allowance (DA) to be merged with basic pay Pensioners may see revised benefits What government employees should prepare for For nearly 35 lakh central government employees and over 67 lakh pensioners, the 8th Pay Commission has become a source of speculation. With growing chatter around possible pay hikes and revised pension benefits, expectations are soaring. Despite the excitement, there's still no official word from the government on when the 8th Pay Commission will be constituted, leaving many in employee unions have begun voicing concern over the delay, urging the government to form the Commission well in advance to ensure timely implementation and reduce uncertainty for both employees and 7th Pay Commission, which came into effect in January 2016, was announced nearly two years prior, in February 2014. That timeline gave enough room for report submission, cabinet approval, and a timely rollout. However, as of mid-2025, the 8th Pay Commission is yet to be formed, and the crucial Terms of Reference (ToR), which define the scope and goals of the commission, haven't been finalised officials have confirmed that internal discussions are underway, but given the pace of bureaucratic processes, the rollout may stretch well beyond the expected January 1, 2026 timeline. Even if the Commission is announced by the end of this year, historical patterns indicate a gap of 18-24 months before the recommendations are ready for implementation. At this pace, the hike might only materialise by late 2026 or early to the delay are fiscal constraints, with the government balancing welfare spending, election promises, and fiscal deficit targets. A generous hike could significantly strain the exchequer, prompting policymakers to tread carefully.A major part of the salary revision hinges on the fitment factor, Fitment factor is the number used to recalculate an employee's basic salary. In the 7th Pay Commission, this was set at 2.57, raising the minimum pay from Rs 7,000 to Rs 18,000. Going by the views expressed by various experts 8th Pay Commission could recommend a fitment factor between 2.5 and 2.86. "Considering the inflation factor, there are indications that the fitment factor may stay between 2.5- 2.8 times, which will give a significant boost to employee salaries between Rs 40,000 and Rs 45,000," says Krishnendu Chatterjee, Vice President at the top-end 2.86 figure is accepted, the minimum basic salary could climb to over Rs 51,000. However, due to its fiscal implications, such a steep hike may be challenging. A 2.6x to 2.7x hike appears to be more likely, providing a significant increase while keeping the government's finances in fitment factor for the 7th Pay Commission was 2.57 and the minimum basic salary was hiked to Rs 18,000 from Rs 7,000. For the 6th Pay Commission, the fitment factor was 1.86 and the minimum basic salary was raised from Rs 2,750 to Rs 7, likely shift is the merger of the Dearness Allowance with the basic salary. Currently pegged at around 55% effective from January 2025, DA helps offset the impact of inflation and is revised twice in a year. Before the effective date of 8th Pay Commission early next year, there is one more DA hike is due to be announced in coming months which will be effective from July 2025. When a new Pay Commission is implemented, DA accumulated up to that point is typically merged into the revised basic this increases the overall salary package, it also means future DA hikes start from zero. Employees will see a rise in gross salary and related allowances, such as HRA and transport, but may also experience low DA in the near term. However, a higher base salary will mean that each DA hike will mean a higher increase in implementation of the 8th Pay Commission is not only being eagerly awaited by salaried employees. Nearly 67 lakh government pensioners are also impacted by any revision in the pay scale. Previous Pay Commissions have included changes in pension calculation formulas and benefits, and similar adjustments are expected this time as merger of Dearness Relief (DR) into basic pension also affects pensioners, as their payouts are tied to similar structures. Any revision in the base figures could significantly alter monthly pension employees' associations have echoed the concerns of serving staff, pushing for greater clarity from the government on how pension recalculations will be carried out in the new the uncertainty, a few things seem inevitable. A revised pay structure is coming, but it may take longer than expected. The eventual hike could push minimum salaries up to Rs 40,000 - Rs 45,000, with pension adjustments following suit. DA will reset, but higher allowances may offset the initial flattening in salary government staff would do well to temper expectations, at least in terms of timing. The gains could be significant, but the road to them may be more drawn out than previous 8th Pay Commission is aimed to deliver significant financial changes for government employees and pensioners. Yet, the pace of bureaucracy, pending approvals, and fiscal balancing may delay the implementation beyond the earlier-set target of January 2026.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store